201 related articles for article (PubMed ID: 19716839)
21. Palytoxin is a non-12-O-tetradecanoylphorbol-13-acetate type tumor promoter in two-stage mouse skin carcinogenesis.
Fujiki H; Suganuma M; Nakayasu M; Hakii H; Horiuchi T; Takayama S; Sugimura T
Carcinogenesis; 1986 May; 7(5):707-10. PubMed ID: 2870823
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity studies of the nonphorbol tumor promoter palytoxin in Swiss 3T3 cells.
Wattenberg EV; Uemura D; Byron KL; Villereal ML; Fujiki H; Rosner MR
Cancer Res; 1989 Nov; 49(21):5837-42. PubMed ID: 2571412
[TBL] [Abstract][Full Text] [Related]
23. Activation of epidermal akt by diverse mouse skin tumor promoters.
Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
[TBL] [Abstract][Full Text] [Related]
24. Sodium as a mediator of non-phorbol tumor promoter action. Down-modulation of the epidermal growth factor receptor by palytoxin.
Wattenberg EV; Byron KL; Villereal ML; Fujiki H; Rosner MR
J Biol Chem; 1989 Sep; 264(25):14668-73. PubMed ID: 2570066
[TBL] [Abstract][Full Text] [Related]
25. Involvement of (Na+ + K+)-ATPase in binding and actions of palytoxin on human erythrocytes.
Böttinger H; Béress L; Habermann E
Biochim Biophys Acta; 1986 Sep; 861(1):165-76. PubMed ID: 2875735
[TBL] [Abstract][Full Text] [Related]
26. Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol-13-acetate-type tumor promoter.
Wattenberg EV; Fujiki H; Rosner MR
Cancer Res; 1987 Sep; 47(17):4618-22. PubMed ID: 2887282
[TBL] [Abstract][Full Text] [Related]
27. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5.
Marinissen MJ; Chiariello M; Pallante M; Gutkind JS
Mol Cell Biol; 1999 Jun; 19(6):4289-301. PubMed ID: 10330170
[TBL] [Abstract][Full Text] [Related]
28. Palytoxin. Recent electrophysiological and pharmacological evidence for several mechanisms of action.
Frelin C; Van Renterghem C
Gen Pharmacol; 1995 Jan; 26(1):33-7. PubMed ID: 7713364
[TBL] [Abstract][Full Text] [Related]
29. Ouabain inhibits the increase due to palytoxin of cation permeability of erythrocytes.
Habermann E; Chhatwal GS
Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):101-7. PubMed ID: 6125898
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of prostaglandin E2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide.
Ohuchi K; Watanabe M; Yoshizawa K; Tsurufuji S; Fujiki H; Suganuma M; Sugimura T; Levine L
Biochim Biophys Acta; 1985 Mar; 834(1):42-7. PubMed ID: 2858221
[TBL] [Abstract][Full Text] [Related]
31. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
[TBL] [Abstract][Full Text] [Related]
32. Effects of apical vs. basolateral palytoxin on LLC-PK1 renal epithelia.
Mullin JM; Snock KV; McGinn MT
Am J Physiol; 1991 Jun; 260(6 Pt 1):C1201-11. PubMed ID: 1676241
[TBL] [Abstract][Full Text] [Related]
33. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
[TBL] [Abstract][Full Text] [Related]
34. PP1/PP2A phosphatases inhibitors okadaic acid and calyculin A block ERK5 activation by growth factors and oxidative stress.
Garcia L; Garcia F; Llorens F; Unzeta M; Itarte E; Gómez N
FEBS Lett; 2002 Jul; 523(1-3):90-4. PubMed ID: 12123810
[TBL] [Abstract][Full Text] [Related]
35. Palytoxin acts through Na+,K+-ATPase.
Habermann E
Toxicon; 1989; 27(11):1171-87. PubMed ID: 2575806
[TBL] [Abstract][Full Text] [Related]
36. Palytoxin-induced Na+ influx into yeast cells expressing the mammalian sodium pump is due to the formation of a channel within the enzyme.
Redondo J; Fiedler B; Scheiner-Bobis G
Mol Pharmacol; 1996 Jan; 49(1):49-57. PubMed ID: 8569711
[TBL] [Abstract][Full Text] [Related]
37. Palytoxin binds to and inhibits kidney and erythrocyte Na+, K+-ATPase.
Böttinger H; Habermann E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jan; 325(1):85-7. PubMed ID: 6143267
[TBL] [Abstract][Full Text] [Related]
38. Head and neck cancer cells and xenografts are very sensitive to palytoxin: decrease of c-jun n-terminale kinase-3 expression enhances palytoxin toxicity.
Görögh T; Bèress L; Quabius ES; Ambrosch P; Hoffmann M
Mol Cancer; 2013 Feb; 12():12. PubMed ID: 23409748
[TBL] [Abstract][Full Text] [Related]
39. Ability of okadaic acid and other protein phosphatase inhibitors to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production in mouse epidermis in vivo.
Newell SW; Perchellet EM; Gao XM; Chen G; Perchellet JP
Cancer Lett; 1996 Jan; 98(2):241-51. PubMed ID: 8556715
[TBL] [Abstract][Full Text] [Related]
40. TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.
Yamamoto H; Ryu J; Min E; Oi N; Bai R; Zykova TA; Yu DH; Moriyama K; Bode AM; Dong Z
J Invest Dermatol; 2017 Jun; 137(6):1322-1332. PubMed ID: 28131816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
